Yahoo Finance

Roche’s Elecsys IL-6 test receives FDA Emergency Use Authorisation to help in identifying patients at high risk of severe inflammatory response

Basel, 04 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys® IL-6 test.
Nasdaq

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

This Study performs unique rapid on-site measurement using patient whole blood and positions Company to move forward with multiple initiatives ACTON, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Bluejay ...
Yahoo Finance

Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022

Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care ACTON, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics ...
streetinsider

bluejay Diagnostics (BJDX) Files FDA Pre-Submission Filing Package for the Symphony IL-6 Test

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Bluejay Diagnostics, Inc. (NASDAQ: BJDX) a late-stage, pre-revenue diagnostics company focused on developing ...
Nasdaq

Roche's Elecsys IL-6 Test Gets FDA Approval To Use In COVID-19 Treatment

(RTTNews) - Swiss drug maker Roche (RHHBY) announced Thursday that the U.S. Food and Drug Administration has issued an Emergency Use Authorisation or EUA for the Elecsys IL-6 test to help in ...
newswire

Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission ACTON, Mass., October 6, 2026 (Newswire.com) - Bluejay ...
The Trentonian

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho’s Critical Care Blood Testing Menu

RARITAN, N.J., July 22, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced its VITROS (R) Immunodiagnostic ...
The Globe and Mail

Bluejay Diagnostics Expands Symphony IL-6 Manufacturing Capabilities

An announcement from Bluejay Diagnostics ( (BJDX)) is now available. On October 13, 2026, Bluejay Diagnostics announced it had completed the establishment of a manufacturing site for Symphony ...
streetinsider

bluejay Diagnostics (BJDX) Completes 90 Subjects Clinical Study of Rapid IL-6 Test for COVID-19 Patients in Critical Care

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported that it has completed 90 subjects in the prospective multicenter ...